Targeting the Small GTPase Superfamily through Their Regulatory Proteins

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Ras superfamily small GTPases are crucial guanine-nucleotide-dependent switches in cellular signaling.
• Dysregulation of these GTPases is linked to numerous diseases, yet direct targeting has proven challenging, classifying them as "undruggable".

Purpose of the Study:

• To review recent strategies targeting small GTPases via their regulators.
• To critically assess chemical biology practices and explore future therapeutic avenues.

Main Methods:

• Literature review of small molecule and biologic strategies.
• Critical evaluation of chemical biology approaches, including PAINs motifs and cell-based assays.
• Analysis of regulatory proteins: guanine nucleotide exchange factors (GEFs), GTPase activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs).

Main Results:

• Recent advances focus on targeting GTPase regulators rather than the GTPases directly.
• Identification of potential pitfalls in chemical biology, such as PAINs motifs and compounds with low specificity.
• Exploration of diverse approaches for future drug development.

Conclusions:

• Targeting GTPase regulators offers a promising alternative to directly targeting "undruggable" small GTPases.
• Careful chemical biology practice and validation are essential for developing effective therapeutics.
• Significant potential exists for future therapeutic strategies through regulatory protein modulation.